Literature DB >> 30838316

Brachial Neuritis After Botulinum Toxin Injections for Cervical Dystonia: A Need for a Reappraisal?

Ilaria Cani1, Anna Latorre2,3, Carla Cordivari2,4, Bettina Balint2,5, Kailash P Bhatia2.   

Abstract

BACKGROUND: Brachial neuritis has previously been described as a rare occurrence in patients receiving botulinum toxin for cervical or writing/focal arm dystonia.
METHODS: We report four cases of patients with a long history of cervical dystonia treated with botulinum toxin injections.
RESULTS: All patients developed pain and muscular weakness around the shoulder, with EMG studies suggesting brachial neuritis.
CONCLUSIONS: In the context of these observations, we discuss the question of an association between brachial neuritis and botulinum toxin treatment.

Entities:  

Keywords:  Parsonage‐Turner syndrome; botulinum toxin injections; brachial neuritis; neuralgic amyotrophy

Year:  2018        PMID: 30838316      PMCID: PMC6384191          DOI: 10.1002/mdc3.12710

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  18 in total

1.  The clinical spectrum of neuralgic amyotrophy in 246 cases.

Authors:  Nens van Alfen; Baziel G M van Engelen
Journal:  Brain       Date:  2005-12-21       Impact factor: 13.501

2.  Neuralgic amyotrophy following botulinum toxin injection.

Authors:  Roy N Alcalay; Rita M Simões; Andrew Feigin; Steven Frucht
Journal:  Parkinsonism Relat Disord       Date:  2009-10-07       Impact factor: 4.891

3.  Brachial plexopathy after botulinum toxin injections.

Authors:  R L Glanzman; D J Gelb; I Drury; M B Bromberg; D D Truong
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

4.  The electrodiagnostic natural history of parsonage-turner syndrome.

Authors:  Joseph H Feinberg; Elizabeth T Nguyen; Kwadwo Boachie-Adjei; Caitlin Gribbin; Steve K Lee; Aaron Daluiski; Scott W Wolfe
Journal:  Muscle Nerve       Date:  2017-04-13       Impact factor: 3.217

5.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK.

Authors:  B K MacDonald; O C Cockerell; J W Sander; S D Shorvon
Journal:  Brain       Date:  2000-04       Impact factor: 13.501

6.  Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans.

Authors:  Philip R Deitiker; Minako Oshima; Joseph Jankovic; Drake D Duane; K Roger Aoki; M Zouhair Atassi
Journal:  Autoimmunity       Date:  2010-09-15       Impact factor: 2.815

Review 7.  Molecular basis of immunogenicity to botulinum neurotoxins and uses of the defined antigenic regions.

Authors:  M Z Atassi
Journal:  Toxicon       Date:  2015-06-16       Impact factor: 3.033

Review 8.  Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment.

Authors:  Jeroen J J Van Eijk; Jan T Groothuis; Nens Van Alfen
Journal:  Muscle Nerve       Date:  2016-01-20       Impact factor: 3.217

9.  Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting--a prospective cohort study.

Authors:  Nens van Alfen; Jeroen J J van Eijk; Tessa Ennik; Sean O Flynn; Inge E G Nobacht; Jan T Groothuis; Sigrid Pillen; Floris A van de Laar
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

10.  Parsonage-Turner syndrome following post-exposure prophylaxis.

Authors:  Duncan P Fransz; Casper P Schönhuth; Tjeerd J Postma; Barend J van Royen
Journal:  BMC Musculoskelet Disord       Date:  2014-08-07       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.